4.8 Article

Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium

Journal

BMC MEDICINE
Volume 14, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/s12916-016-0607-5

Keywords

Smoking; Cancer; Incidence; Mortality; Cohort; Meta-analysis

Funding

  1. FP7 framework program of DG-RESEARCH the European Commission [242244]
  2. Swedish Research Council
  3. Swedish Cancer Foundation
  4. Baden-Wurttemberg state Ministry of Science, Research and Arts (Stuttgart, Germany)
  5. Federal Ministry of Education and Research (Berlin, Germany)
  6. Federal Ministry of Family Affairs, Senior Citizens, Women and Youth (Berlin, Germany)
  7. Hellenic Health Foundation
  8. European Commission (DG SANCO)
  9. Dutch Ministry of Public Health, Welfare and Sports (VWS)
  10. National Institute for Public Health and the Environment (RIVM)
  11. Netherlands Cancer Registry (NKR)
  12. Netherlands Organizaton for Health Research and Development (ZONMW)
  13. World Cancer Research Fund (WCRF)
  14. Statistics Netherlands
  15. Health Research Fund (FIS) of the Spanish Ministry of Health RTICC 'Red Tematica de Investigacion Cooperativa en Cancer [Rd06/0070/0091, Rd12/0036/0018]
  16. Regional Governments of Andalucia, Asturias, Basque Country, Murcia [6236]
  17. Navarra, Institute de Salud Carlos III, Redes de Investigacion Cooperativa [RD06/0020]
  18. Swedish Cancer Society
  19. Swedish Scientific Council
  20. Regional Government of Skane
  21. Danish Cancer Society
  22. Welcome Trust [064947, 081081]
  23. US National Institute on Ageing [R01 AG23522]
  24. Mac Arthur Foundation
  25. Institut National de la Sante et de la Recherche Medicale (INSERM), Merck
  26. Sharp & Dohme-Chibret Laboratory
  27. Department of Health and Social Services
  28. Personal Safety for Northern Ireland
  29. European Union [HEALTH-F4-2007-201413, 278913]
  30. Intramural Program of the National Cancer Institute
  31. Erasmus Medical Center
  32. Erasmus University Rotterdam
  33. Netherlands Organization for Scientific Research
  34. Netherlands Organization for Health Research and Development
  35. Research Institute for Diseases in the Elderly
  36. Netherlands Genomics Initiative
  37. Ministry of 'Education Culture, and Science
  38. Ministry of Health, Welfare, and Sports
  39. European Commission
  40. Municipality of Rotterdam
  41. EU
  42. Norwegian Research Council
  43. Vasterbotten county Council
  44. Swedish Council for Working Life and Social Research
  45. Medical Research Council [MC_CF023241] Funding Source: researchfish

Ask authors/readers for more resources

Background: Smoking is the most important individual risk factor for many cancer sites but its association with breast and prostate cancer is not entirely clear. Rate advancement periods (RAPs) may enhance communication of smoking related risk to the general population. Thus, we estimated RAPs for the association of smoking exposure (smoking status, time since smoking cessation, smoking intensity, and duration) with total and site-specific (lung, breast, colorectal, prostate, gastric, head and neck, and pancreatic) cancer incidence and mortality. Methods: This is a meta-analysis of 19 population-based prospective cohort studies with individual participant data for 897,021 European and American adults. For each cohort we calculated hazard ratios (HRs) for the association of smoking exposure with cancer outcomes using Cox regression adjusted for a common set of the most important potential confounding variables. RAPs (in years) were calculated as the ratio of the logarithms of the HRs for a given smoking exposure variable and age. Meta-analyses were employed to summarize cohort-specific HRs and RAPs. Results: Overall, 140,205 subjects had a first incident cancer, and 53,164 died from cancer, during an average follow-up of 12 years. Current smoking advanced the overall risk of developing and dying from cancer by eight and ten years, respectively, compared with never smokers. The greatest advancements in cancer risk and mortality were seen for lung cancer and the least for breast cancer. Smoking cessation was statistically significantly associated with delays in the risk of cancer development and mortality compared with continued smoking. Conclusions: This investigation shows that smoking, even among older adults, considerably advances, and cessation delays, the risk of developing and dying from cancer. These findings may be helpful in more effectively communicating the harmful effects of smoking and the beneficial effect of smoking cessation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available